Company Analysis AstraZeneca PLC
1. Summary
Advantages
- Dividends (1.91%) are higher than the sector average (1.73%).
- The stock's return over the last year (16.29%) is higher than the sector average (-30.35%).
- The company's current efficiency (ROE=15.23%) is higher than the sector average (ROE=12.96%)
Disadvantages
- Price (156.01 $) is higher than fair price (54.07 $)
- Current debt level 27.49% has increased over 5 years from 2.89%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 19:18 J&J COVID-19 vaccine manufacturing halted at US plant that had contamination issue
Other news β¨
2.3. Market efficiency
AstraZeneca PLC | Healthcare | Index | |
---|---|---|---|
7 days | 0.2% | -4.7% | -1% |
90 days | -0.1% | -39% | 5.6% |
1 year | 16.3% | -30.3% | 31.4% |
AZNCF vs Sector: AstraZeneca PLC has outperformed the "Healthcare" sector by 46.63% over the past year.
AZNCF vs Market: AstraZeneca PLC has significantly underperformed the market by -15.07% over the past year.
Stable price: AZNCF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AZNCF with weekly volatility of 0.3132% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (156.01 $) is higher than the fair price (54.07 $).
Price is higher than fair: The current price (156.01 $) is 65.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (35.25) is lower than that of the sector as a whole (117.69).
P/E vs Market: The company's P/E (35.25) is lower than that of the market as a whole (53.07).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.37) is higher than that of the sector as a whole (3.37).
P/BV vs Market: The company's P/BV (5.37) is higher than that of the market as a whole (-9.1).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.47) is lower than that of the sector as a whole (8.16).
P/S vs Market: The company's P/S indicator (4.47) is lower than that of the market as a whole (5.18).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (15.84) is lower than that of the sector as a whole (52.39).
EV/Ebitda vs Market: The company's EV/Ebitda (15.84) is lower than that of the market as a whole (23.95).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 69.21% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (69.21%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-73.51%).
5.4. ROE
ROE vs Sector: The company's ROE (15.23%) is higher than that of the sector as a whole (12.96%).
ROE vs Market: The company's ROE (15.23%) is higher than that of the market as a whole (-2.01%).
5.5. ROA
ROA vs Sector: The company's ROA (5.9%) is lower than that of the sector as a whole (6.09%).
ROA vs Market: The company's ROA (5.9%) is lower than that of the market as a whole (8.98%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-0.09%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (-0.09%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.91% is higher than the average for the sector '1.73%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.91% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 1.91% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (77.06%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription